# Corden Pharma Fribourg SA, Villars-Sur-Glane, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/corden-pharma-fribourg-sa/749b4152-5491-45ed-8d48-4e05eeb96606

> Inspection records and compliance data for Corden Pharma Fribourg SA in Villars-Sur-Glane. 4 FDA inspections on record, 2 Form 483s, last inspected February 03, 2023.

---

## Details

- Name: Corden Pharma Fribourg SA
- FEI Number: 3009018997
- Business Operations: FDF MANUFACTURE
- Address Line 1: Route De Moncor 10
- City: Villars-Sur-Glane
- Country Name: Switzerland
- Address: Route De Moncor 10, Villars-Sur-Glane, Switzerland
- Country: Switzerland

## Related Documents

- [483 - Corden Pharma Fribourg SA - 2023-02-03](https://www.keypedia.com/records/483/corden-pharma-fribourg-sa/3a01de4a-ae1d-4a69-97a4-e83db8b94ead) — source: FDA, date: February 3, 2023
- [FDA Inspection 1197386 - Corden Pharma Fribourg SA - 2023-02-03](https://www.keypedia.com/records/fda_inspections/corden-pharma-fribourg-sa/f32fd49c-45a8-454c-855a-5251409e97b1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1061458 - Corden Pharma Fribourg SA - 2018-06-15](https://www.keypedia.com/records/fda_inspections/corden-pharma-fribourg-sa/859d13a0-a8a6-4757-846e-56b5e764a3c0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 15, 2018
- [FDA Inspection 883319 - Corden Pharma Fribourg SA - 2014-06-05](https://www.keypedia.com/records/fda_inspections/corden-pharma-fribourg-sa/66c8b651-7318-46e7-927a-6b60f6a9fa4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 5, 2014
- FDA Inspection 802561 - Corden Pharma Fribourg SA - 2012-06-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2012

## Related Companies

- [Rivopharm S.A.](https://www.keypedia.com/companies/rivopharm-sa/7cc8f5f7-352e-451c-bd6f-5abaec132ce0)
- [Lexenpharm (Suzhou) Limited](https://www.keypedia.com/companies/lexenpharm-suzhou-limited/7583aa85-4a9c-4db2-ad49-6d411885ad5f)
- [BioDuro, LLC](https://www.keypedia.com/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)
- [Haupt Pharma Muenster GmbH](https://www.keypedia.com/companies/haupt-pharma-muenster-gmbh/09cdc4cc-6cbc-4904-baa2-d4013dae9741)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Mission Hills, S.A. de C.V.](https://www.keypedia.com/companies/mission-hills-sa-de-cv/b3b00bab-bd17-4495-92bf-820e72193c5b)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/c97ec28f-0a83-47f4-ac75-571afa3c6194)
- [Xiamen LP Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/xiamen-lp-pharmaceutical-co-ltd/fb23c997-3591-4cab-a4f2-17802b76cb23)
- [Granules India Limited](https://www.keypedia.com/companies/granules-india-limited/e2f27ea6-6e3b-4432-a874-d34393d76014)
- [Oishi Koseido Co., Ltd.](https://www.keypedia.com/companies/oishi-koseido-co-ltd/07ae7f38-2728-4248-8ef1-ff0abd9a79e7)

## Related Officers

- [ Investigator ](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)